{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:12:05Z","timestamp":1791976325195,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tmreviews.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.tmrv.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T17:51:16Z","timestamp":1490205076000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Safety and Efficacy of Lysine Analogues in Cancer Patients: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Joshua","family":"Montroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke T","family":"Lavall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1363-8137","authenticated-orcid":false,"given":"Chris","family":"Morash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Cagiannos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney H","family":"Breau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.tmrv.2017.03.002_bb0005","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood-2008-07-077370","article-title":"The hazards of blood transfusion in historical perspective","volume":"112","author":"Alter","year":"2008","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.tmrv.2017.03.002_bb0010","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMra067742","article-title":"Prevention and treatment of major blood loss","volume":"356","author":"Mannucci","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.tmrv.2017.03.002_bb0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jss.2013.07.042","article-title":"Patterns of use of hemostatic agents in patients undergoing major surgery","volume":"186","author":"Wright","year":"2014","journal-title":"J Surg Res"},{"issue":"9734","key":"10.1016\/j.tmrv.2017.03.002_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tmrv.2017.03.002_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tmrv.2014.05.002","article-title":"The effects of lysine analogues during pelvic surgery: a systematic review and meta-analysis","volume":"28","author":"Breau","year":"2014","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006640.pub3","article-title":"Tranexamic acid for upper gastrointestinal bleeding","volume":"11","author":"Bennett","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jcp.33.Suppl_14.41","article-title":"Clinical pharmacology of aminocaproic and tranexamic acids","volume":"14","author":"Nilsson","year":"1980","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"issue":"3","key":"10.1016\/j.tmrv.2017.03.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001886.pub3","article-title":"Anti-fibrinolytic use for minimising perioperative allogenic blood transfusion","volume":"16","author":"Henry","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5798","article-title":"Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies","volume":"345","author":"Hutton","year":"2012","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.tmrv.2017.03.002_bb0050","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s00586-013-2774-9","article-title":"Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials","volume":"22","author":"Li","year":"2013","journal-title":"Eur Spine J"},{"issue":"5","key":"10.1016\/j.tmrv.2017.03.002_bb0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2008.09.015","article-title":"Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials","volume":"123","author":"Kagoma","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0060","series-title":"19th WHO model list of essential medicines (April 2015)","author":"WHO","year":"2015"},{"issue":"7975","key":"10.1016\/j.tmrv.2017.03.002_bb0065","first-page":"49","article-title":"Does prophylactic tranexamic acid safely reduce bleeding without increasing thrombotic complications in patients undergoing cardiac surgery?","volume":"2","author":"Thiagarajamurthy","year":"2004","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"12","key":"10.1016\/j.tmrv.2017.03.002_bb0070","first-page":"456","article-title":"Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy","volume":"43","author":"Woo","year":"1989","journal-title":"Br J Clin Pract"},{"issue":"4","key":"10.1016\/j.tmrv.2017.03.002_bb0075","first-page":"306","article-title":"Tranexamic acid and acute myocardial infarction","volume":"12","author":"Mandal","year":"2005","journal-title":"Br J Cardiol"},{"issue":"1","key":"10.1016\/j.tmrv.2017.03.002_bb0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/157488612800492744","article-title":"The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials","volume":"7","author":"Ross","year":"2012","journal-title":"Curr Drug Saf"},{"issue":"5","key":"10.1016\/j.tmrv.2017.03.002_bb0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1634\/theoncologist.9-5-561","article-title":"Management of bleeding in patients with advanced cancer","volume":"9","author":"Pereira","year":"2004","journal-title":"Oncologist"},{"issue":"9109","key":"10.1016\/j.tmrv.2017.03.002_bb0090","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(97)10018-6","article-title":"Venous thromboembolism and cancer","volume":"351","author":"Baron","year":"1998","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.tmrv.2017.03.002_bb0095","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM199210153271611","article-title":"Cancer and cloting\u2014Trousseau's warning","volume":"327","author":"Silverstein","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0100","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7326\/0003-4819-96-5-556","article-title":"Occult cancer in patients with acute pulmonary embolism","volume":"95","author":"Gore","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0105","first-page":"117","article-title":"Venous thromboembolism and cancer: risks and outcomes","volume":"208","author":"Lee","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tmrv.2017.03.002_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-6143.2006.01591.x","article-title":"Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis","volume":"7","author":"Molenaar","year":"2007","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.tmrv.2017.03.002_bb0115","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00383-012-3167-6","article-title":"A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use","volume":"28","author":"Basta","year":"2012","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"10.1016\/j.tmrv.2017.03.002_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.joms.2015.05.031","article-title":"Prevention of bleeding in orthognathic surgery-a systematic review and meta-analysis of randomized controlled trials","volume":"74","author":"Olsen","year":"2016","journal-title":"J Oral Maxillofac Surg"},{"issue":"12","key":"10.1016\/j.tmrv.2017.03.002_bb0125","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ajem.2014.09.023","article-title":"Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis","volume":"32","author":"Zehtabchi","year":"2014","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009733.pub3","article-title":"Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders","volume":"3","author":"Estcourt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011732.pub2","article-title":"Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer","volume":"1","author":"Kietpeerakool","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001421.pub3","article-title":"Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia","volume":"12","author":"Martin-Hirsch","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7\u20138","key":"10.1016\/j.tmrv.2017.03.002_bb0145","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/106002809603000728","article-title":"Tranexamic acid in oncology","volume":"30","author":"Seto","year":"1996","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.tmrv.2017.03.002_bb0150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0155","author":"Higgins"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0160","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0165","unstructured":"Sch\u00fcnemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0, 2011"},{"issue":"9655","key":"10.1016\/j.tmrv.2017.03.002_bb0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(89)90181-5","article-title":"Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia","volume":"2","author":"Avvisati","year":"1989","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.tmrv.2017.03.002_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10428199509059668","article-title":"A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia","volume":"19","author":"Shpilberg","year":"1995","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.tmrv.2017.03.002_bb0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00000542-200302000-00011","article-title":"Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery","volume":"98","author":"Amar","year":"2003","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.tmrv.2017.03.002_bb0185","first-page":"637","article-title":"The role of antifibrinolytic agents in gynecologic cancer surgery","volume":"27","author":"Celebi","year":"2006","journal-title":"Saudi Med J"},{"issue":"4","key":"10.1016\/j.tmrv.2017.03.002_bb0190","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/00016347209156871","article-title":"The effect of tranexamic acid (AMCA) on postoperative bleeding after conisation","volume":"51","author":"Rybo","year":"1972","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.tmrv.2017.03.002_bb0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.sla.0000197561.70972.73","article-title":"Perioperative parenteral tranexamic acid in live tumor resection: a prospective randomized trial toward a \u201cblood transfusion\u201d-free hepatectomy","volume":"243","author":"Wu","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0200","doi-asserted-by":"crossref","first-page":"d5701","DOI":"10.1136\/bmj.d5701","article-title":"Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial","volume":"343","author":"Crescenti","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.tmrv.2017.03.002_bb0205","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/aogs.12333","article-title":"Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study","volume":"93","author":"Lundin","year":"2014","journal-title":"Acta Obstet Gynecol Scan"},{"issue":"1","key":"10.1016\/j.tmrv.2017.03.002_bb0210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/1658-354X.146304","article-title":"Effect of low dose tranexamic acid on intra-operative blood loss in neurosurgical patients","volume":"9","author":"Vel","year":"2015","journal-title":"Saudi J Anaesth"},{"issue":"3","key":"10.1016\/j.tmrv.2017.03.002_bb0215","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4103\/0259-1162.161806","article-title":"Does the preoperative administration of tranexamic acid reduce perioperative blood loss and transfusion requirements after head neck cancer surgery? A randomized, controlled trial","volume":"9","author":"Das","year":"2015","journal-title":"Anesth Essays Res"},{"issue":"1","key":"10.1016\/j.tmrv.2017.03.002_bb0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0019-5049.174798","article-title":"Does tranexamic acid reduce blood loss during head and neck cancer surgery?","volume":"60","author":"Kulkarni","year":"2016","journal-title":"Indian J Anaesth"},{"issue":"1","key":"10.1016\/j.tmrv.2017.03.002_bb0225","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/aogs.12798","article-title":"Tranexamic acid for preventing postpartum blood loss after caesarean delivery: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Simonazzi","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"10.1016\/j.tmrv.2017.03.002_bb0230","doi-asserted-by":"crossref","first-page":"e0137886","DOI":"10.1371\/journal.pone.0137886","article-title":"Efficacy and safety of antifibrinolytic agents in reducing perioperative blood loss and transfusion requirements in scoliosis surgery: a systematic review and meta-analysis","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0235","doi-asserted-by":"crossref","first-page":"e3054","DOI":"10.1136\/bmj.e3054","article-title":"Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis","volume":"344","author":"Ker","year":"2012","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.tmrv.2017.03.002_bb0240","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ajg.2008.22","article-title":"Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials","volume":"104","author":"Keus","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.tmrv.2017.03.002_bb0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/sim.2528","article-title":"Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events","volume":"26","author":"Bradburn","year":"2007","journal-title":"Stat Med"},{"issue":"9","key":"10.1016\/j.tmrv.2017.03.002_bb0250","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.tmrv.2017.03.002_bb0255","doi-asserted-by":"crossref","first-page":"e1001666","DOI":"10.1371\/journal.pmed.1001666","article-title":"Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials","volume":"11","author":"Dwan","year":"2014","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.tmrv.2017.03.002_bb0260","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1191\/0962280205sm415oa","article-title":"Outcome selection bias in meta-analysis","volume":"14","author":"Williamson","year":"2005","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.tmrv.2017.03.002_bb0265","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.critrevonc.2016.05.017","article-title":"Reporting adverse events in cancer surgery randomized trials: a systematic review of published trials in oesophago-gastric and gynecological cancer patients","volume":"104","author":"Meghelli","year":"2016","journal-title":"Crit Rev Hematol"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796316301705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796316301705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T04:54:40Z","timestamp":1535950480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796316301705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0887796316301705"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2017.03.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Safety and Efficacy of Lysine Analogues in Cancer Patients: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}